Browse the evidence

A ketogenic diet significantly improves quality of life (QoL) and reduces fatigue symptoms in individuals with overweight, particularly those with high baseline fatigue.

If you are overweight and struggle with fatigue, a ketogenic diet may help boost your energy and overall quality of life. This benefit seems most pronounced if you already feel fatigued. Stick to the diet for at least three months, ensure you are in ketosis, and monitor how your energy levels change.

Weight loss acts as a significant moderator for the effect of combined interventions on visceral fat area (VFA), but not for liver fat or intramuscular triglycerides (IMTG).

Losing weight helps reduce visceral fat, but it may not be enough to reduce liver or muscle fat. If you have concerns about liver or muscle fat, you may need additional strategies beyond just weight loss.

Long-term weight loss via lifestyle interventions reduces cervical subcutaneous adipose tissue (cervical-SAT) significantly, whereas chin subcutaneous adipose tissue (chin-SAT) shows a significant initial reduction but rebounds to baseline levels after 18 months.

If you are losing weight, expect your neck fat to decrease more sustainably than chin fat. While you may see an initial reduction in chin fat, it is likely to return as you maintain your weight long-term, whereas neck fat reduction is more persistent. This does not mean weight loss is ineffective, but rather that fat distribution changes are depot-specific.

Reduction in chin subcutaneous adipose tissue (chin-SAT) is independently associated with improvements in glycemic control (fasting glucose, HbA1c, HOMA-IR) and lipid profiles, even after adjusting for changes in visceral adipose tissue (VAT) and waist circumference.

Losing chin fat may be a sign of improving metabolic health, specifically insulin sensitivity. While you cannot spot-reduce, the reduction of this specific fat depot correlates with better blood sugar control, independent of how much belly fat you lose.

Reduction in cervical subcutaneous adipose tissue (cervical-SAT) is independently associated with improvements in lipid profiles (triglycerides, LDL-C, cholesterol/HDL ratio) and leptin levels, independent of visceral adipose tissue (VAT).

Losing neck fat may be a sign of improving metabolic health, specifically lipid profiles and leptin sensitivity. While you cannot spot-reduce, the reduction of this specific fat depot correlates with better blood lipid control, independent of how much belly fat you lose.

Time-restricted eating (TRE) combined with caloric restriction (CR) does not yield superior weight loss compared to caloric restriction alone in overweight and obese women.

If you are already restricting calories to lose weight, adding a strict eating window may not give you any extra weight loss benefit. You can achieve similar results with just calorie control.

A 1-month very-low-calorie ketogenic diet (VLCKD) in women with obesity causes a significant reduction in 24-hour energy expenditure (24hEE) and sleeping metabolic rate (SMR), primarily driven by the loss of lean soft tissue (LST) rather than metabolic adaptation alone.

If you follow a very-low-calorie ketogenic diet, expect your daily calorie burn to drop by about 10% after a month. This isn't just 'metabolic damage'; it's largely because you are lighter and have lost some muscle. To protect your metabolism, prioritize the protein target (1.2-1.5g/kg ideal body weight) and incorporate light resistance or walking to preserve lean tissue.

A 1-month VLCKD shifts substrate oxidation to favor fat and protein, resulting in a 62% fat mass loss and 38% lean soft tissue loss of total weight lost.

On a VLCKD, you will lose fat and muscle. In this study, 38% of the weight lost was lean tissue. To minimize this, ensure you are eating enough protein (1.2-1.5g/kg ideal body weight) and engaging in resistance exercise.

GLP-1 receptor agonists (e.g., semaglutide, liraglutide) achieve 10-15% weight loss and superior metabolic improvements compared to lifestyle changes alone, but are recommended for non-responders or those with comorbidities.

If lifestyle changes alone do not achieve sufficient weight loss or if you have obesity-related comorbidities, discuss GLP-1 receptor agonists (like semaglutide or liraglutide) with your doctor. These medications can lead to 10-15% weight loss and significant metabolic improvements, though they may cause gastrointestinal side effects. They are most effective when combined with lifestyle modifications.

Intermittent fasting (IF) produces weight loss and metabolic improvements comparable to continuous caloric restriction (CCR) in adults with overweight or obesity, without providing superior benefits.

If you are overweight or obese, intermittent fasting is a viable option for weight loss, but do not expect it to work better than simply eating fewer calories every day. Studies show that IF and continuous calorie restriction lead to similar weight loss (around 5% of body weight) and metabolic improvements over a year. Choose the method that you can stick with long-term, as adherence is key.

Lactobacillus sp. supplementation is safe and well-tolerated in non-comorbid obese individuals, with no significant adverse events reported.

You can take Lactobacillus probiotics with confidence regarding safety. Clinical trials show they are well-tolerated with no significant increase in side effects compared to a placebo.

Tirzepatide produces significant weight loss (mean 18.73%) and improves quality of life in overweight or obese adults without diabetes, but significantly increases the risk of adverse events compared to placebo.

Tirzepatide is a highly effective treatment for weight loss in non-diabetic overweight or obese adults, producing an average 18.73% body weight loss. However, it comes with a significantly higher risk of adverse events, particularly gastrointestinal issues, compared to placebo. Patients should be monitored closely for these side effects.

Increasing exercise volume from 3 sessions/week to 6 sessions/week further reduces fat mass and visceral adipose tissue, although the difference in fat-free mass preservation between 3 and 6 sessions was not statistically significant for absolute fat-free mass kg.

Even 3 days of exercise per week, combined with diet, significantly improves fat loss compared to diet alone. You do not need 6 days to see benefits, but 6 days provides greater fat loss and better muscle preservation.

Higher baseline body weight and BMI strongly predict greater absolute weight loss and fat mass reduction on a very low-calorie ketogenic diet (VLCKD), with men losing significantly more weight than women.

If you have a higher starting weight, you are likely to lose more absolute weight on a VLCKD than someone with a lower starting weight. Men also tend to lose more weight than women on this specific protocol. Use your baseline weight as a predictor of success rather than comparing yourself to others with different starting points.

Intermittent fasting downregulates enteroendocrine signaling, specifically GLP-1, GCG, and PYY, while upregulating PPAR-α, which correlates with improved lipid profiles.

The molecular changes observed (PPAR-α upregulation, GLP-1 downregulation) suggest that IF works by altering how your body processes fats and regulates hormones, not just by restricting calories. This may inform future targeted therapies.

The cardiovascular benefits of low-carbohydrate diets depend on the quality of macronutrients used to replace carbohydrates, not the degree of restriction itself.

If you reduce carbs, ensure you replace them with healthy foods like fiber-rich grains or unsaturated fats, not saturated fats. Simply cutting carbs without considering food quality does not improve heart health.

Flexible time-restricted eating leads to a spontaneous reduction in total energy intake without altering macronutrient composition.

If you use an 8-hour eating window, you will likely eat fewer calories without needing to count them or change your food choices. This spontaneous reduction in energy intake is a key driver of the fat loss seen with flexible TRE.

Increasing the regularity of meal times (reducing mealtime variability) leads to significant weight loss without the need for calorie restriction or changes in macronutrient composition.

Use a smartphone app to track your meals for two weeks. Identify the specific times you eat most frequently. Then, for the next six weeks, restrict your eating to only those specific times, aiming for a consistency of within 45 minutes of your usual times. Do not worry about changing what or how much you eat. This regularity helps your body's internal clock optimize metabolism, leading to weight loss.

Semaglutide improves glycemic control and metabolic parameters in patients with Type 2 Diabetes and obesity.

For those with Type 2 Diabetes, semaglutide helps manage blood sugar and aids in weight loss, though the weight loss effect may be more modest compared to non-diabetic patients.

Exercise frequency positively correlates with gut microbial diversity and the abundance of beneficial bacteria (e.g., Faecalibacterium, Roseburia) that produce short-chain fatty acids (SCFAs), enhancing intestinal barrier function.

Regular physical activity boosts gut bacterial diversity and increases beneficial bacteria that produce SCFAs, which strengthen the gut barrier. Aim for daily exercise to support a healthy microbiome.

Dietary composition directly and rapidly alters gut microbiome composition, with plant-based diets increasing beneficial SCFA-producing bacteria (Bifidobacteria, Lactobacilli) and animal-based/high-fat diets increasing bile-tolerant anaerobes (Bacteroides, Bilophila) and pro-inflammatory pathways.

Focus on the type of food rather than just calories. Plant-based proteins (pea, whey) and fibers increase beneficial bacteria that produce anti-inflammatory short-chain fatty acids. Animal proteins and high saturated fats tend to increase bile-tolerant bacteria linked to inflammation. Prioritize whole food sources of carbohydrates (fiber) over artificial sweeteners to support a healthy microbiome.

High adherence to a Mediterranean diet is associated with increased fecal SCFAs and Prevotella abundance, while low adherence is linked to elevated urinary TMAO and increased cardiovascular risk.

Adopting a Mediterranean-style diet—rich in fiber, polyphenols, and unsaturated fats—supports beneficial bacteria (Prevotella) and reduces harmful metabolites (TMAO). This pattern is linked to lower cardiovascular risk and reduced inflammation.

Curcumin supplementation (1g/day with 10mg piperine) significantly reduces serum concentrations of pro-inflammatory cytokines (TNF-α, IL-6, TGF-β, MCP-1) and improves lipid profiles in patients with Metabolic Syndrome.

If you have metabolic syndrome, taking 1 gram of curcumin with 10 mg of piperine daily for 8 weeks can significantly lower inflammatory markers like TNF-α and IL-6, and improve your cholesterol and triglyceride levels compared to a placebo.

Insulin resistance causes dyslipidemia characterized by high triglycerides, low HDL, and small dense LDL, which significantly increases the incidence of cardiovascular disease.

Insulin resistance changes your lipid profile in a dangerous way: high triglycerides, low HDL, and small dense LDL. This specific combination is highly atherogenic. Managing insulin sensitivity is key to improving this profile.